Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Chemoprophylaxis for Blinatumomab Neurotoxicity in ALL
NCT05519579Phase 2Recruiting
- Sponsor
- Northside Hospital
- Start
- Jun 2023
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Northside Hospital. Started Jun 2023; status: recruiting.
02
Drugs
methotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05519579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05519579.